Collagen-Based Corneal Substitutes with Incorporated Anti-infective Peptide LL37 Sustalined Deivery System
DOI:
https://doi.org/10.31288/oftalmolzh20151110114Keywords:
artificial cornea, antiinfective peptide LL37, sustained delivery systemAbstract
Purpose. To develop corneal substitutes (CS) with a dual function:1) corneal stroma substitute, and 2) antiinfective peptide (AIP) delivery.
Methods. AIP LL37 (cathelicidin) was encapsulated in silica nanoparticles (SINP) under the effect of magnetic field. SiNP with LL37 were then introduced in CS during their production using the method of creation of interpenetrating network of type I collagen and 2 methacryloyloxyethylphosphorylcholine. Dynamics of LL37 release from CS using ELISA method was evaluated. Refractive properties of CS with incorporated AIP release system were assessed using Abbe refractometer. Cytotoxicity of the CS to the cells of the human corneal epithelium was assessed by using WST-1 based colorimetric assay. Mechanical properties were checked by performing lamellar keratoplasty on ex vivo porcine eyes.
Results. Gradual release of LL37 from within CS occurred up to 21day. Release from control CS (with incorporated free LL37) stopped on the 1st day. Refractive index (RI) of CS with LL37 in SiNP was equal to 1.3 (human cornea 1.37). There was no increased cytotoxicity of CS with incorporated release system compared to clear CS. Mechanical strength of CS with LL37 was non-significantly lower compared to clear CS.
Conclusion. For the first time CS containing AIP sustained delivery system was developed. Gradual release of AIP LL37 from within CS was proved. No cell toxicity, satisfactory optical and mechanical properties of the constructs were found.
References
1.Buznyk OI. The sustained delivery system of the anti-infection peptide LL37 system - a potentially new treatment method of ocular infections. Report 1. Testing of different nano- and microparticles as carriers of LL37. Oftalmol Zh. 2014;2:17-21. In Russian. https://doi.org/10.31288/oftalmolzh201421721
2.Gaidamaka TB. Recurrent herpetic keratitis. Pathogenesis, diagnosis, treatment, and prevention: Author's thesis for Doctor of Med. Science. 14.01.18. Ophthalmology. SI «The Filatov Institute of Eye Diseases and Tissue Therapy of NAMS of Ukraine». Odessa, 2011. 44 p.
3.Islam M. M., Griffith M., Mondal D., Buznyk O. I. Anti-infection peptide LL37 sustained delivery system - a potential new treatment of ocular infections. Report 2. Antiviral activity of LL37 incapsulated in silica nanoparticles. Oftalmol Zh. 2014;3:53-7.https://doi.org/10.31288/oftalmolzh201435357
4.Pasyechnikova N, Buznyk A, Yakymenko S et al. Sustained delivery system of the antiinfection peptide LL37 - a potential new method of treat¬ment of ocular infections. Report 3. Antimicrobial activity of LL37 encapsulated in silica nanoparticle. Oftalmol Zh. In printing.
5.Bareiss B, Ghorbani M, Li F et al. Controlled release of acyclovir through bioengineered corneal implants with silica nanoparticle carriers. B. Bareiss. Open Tissue Eng. Regen. Med. J. 2010;3:10-7.https://doi.org/10.2174/1875043501003010010
6.Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D. Antibiotic discovery in the twenty-first century: Current trends and future perspectives. J. Antibiot. (Tokyo). 2010;63(8):423-30.https://doi.org/10.1038/ja.2010.62
7.Fagerholm P, Lagali NS, Merrett K et al. A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci. Transl. Med. 2010;2:46-61.https://doi.org/10.1126/scitranslmed.3001022
8.Gordon YJ, Huang LC, Romanowski EG et al. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. 2005;30(5):385-94.https://doi.org/10.1080/02713680590934111
9.Griffith M, Polisetti N, Kuffova L et al. Regenerative approaches as alternatives to donor allografting for restoration of corneal function. Ocul. Surf. 2012;10(3): 170-83.https://doi.org/10.1016/j.jtos.2012.04.004
10.Liu W, Deng C, McLaughlin CR et al. Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials. 2009;30:1551-9.https://doi.org/10.1016/j.biomaterials.2008.11.022
11.Pasyechnikova N, Vit V, Leus M et al. Collagen-based bioengineered substitutes of donor corneal allograft implantation: assessment and hypotheses. Med. Hypothesis Discov. Innov. Ophthalmol. 2012;1(1);10-3.
12.Sangwan VS, Gopinathan U, Garg P, Rao GN. Eye Banking in India: A Road Ahead. JIMSA.2010;23(3):197-200.
13.Sharma N, Sachdev R, Jhanji V et al. Therapeutic keratoplasty for microbial keratitis. Curr. Opinion Ophthalmol. 2010;21:293-300.https://doi.org/10.1097/ICU.0b013e32833a8e23
14.Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull. World Health Organ. 2001;79:214-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 О. І. Бузник, Н. В. Пасєчнікова, С. А. Якименко, М. М. Іслам, М. Гріффіт
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
